Admission Date:  [**2173-10-7**]              Discharge Date:   [**2173-11-9**]  Date of Birth:  [**2104-1-28**]             Sex:   F  Service: NEUROLOGY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 4583**] Chief Complaint: Weakness  Major Surgical or Invasive Procedure: L1/2 Decompressive Lumbar Laminectomy Intubation Tracheostomy EGD   History of Present Illness: 69 year old Spanish speaking female transferred from [**Hospital **] Rehab facility for evaulation of progressively worsening lower extremity weakness and a constellation of other symptoms.
MRI from [**Hospital 8**] Hospital, [**2173-9-29**]: LUMBAR SPINE: L1-L2: There is a focal left paracentral disc protrusion and a broad based right paracentral to extraforaminal disc protrusion, with associated spondylitic ridging.
MRI HEAD: Results are unavailable   Brief Hospital Course: Ms. [**Known lastname **] is a 69 year-old woman with a past medical history including obesity, DMII, hyperlipidemia, and cervical spondylosis who was admitted to the [**Hospital1 18**] [**2173-10-7**] with with lower extremity weakness and was found to have stenosis at L1-2 for which she underwent laminectomy; she subsequently developed progressive weakness in the lower extremities, upper extremities, and face and was discovered to have evidence of AIDP.
She was re-evaluted by Neurology, who found her facial weakness to be worse, with complaints of dysarthria, dysphagia, and mild dyspnea.
On [**10-19**], after completing her course of IVIG, she underwent a successful SBT and was extubated.
Ultimately, a tracheostomy was performed.
She continued to receive oxygen supplementation via tracheostomy during the remainder of her hospital stay.
Sputum culture demonstrated gram positive cocci in clusters for which IV vancomycin was begun ([**2173-10-28**]) and subsequently switched to nafcillin after it was determined to be coagualase positive staph sensitive to nafcillin.
Nafcillin was discontinued after one week.
For a concurrent urinary tract infection, ciprofloxacin was initiated ([**2173-10-28**]) and continued for a ten day course.
It was determined that flagyl should be continued for a 14 day course.
The last dose of flagyl should be given on [**2173-11-12**].
# GI Tube feeds were provided to ensure adequate nutritional intake throughout the hospitalization.
So that she could receive adequate nutritional support, she had a PEG tube placed on [**2173-11-5**].
Metformin 500mg daily 2.
Tylenol PRN 3.
Vitamin D 4.
ASA 81mg Daily   Discharge Medications: 1.
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Glycerin (Adult)     Suppository Sig: One (1) Suppository Rectal DAILY (Daily) as needed for constipation.
Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day).
Famotidine 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours): Please give via PEG.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation: Please give via PEG.
Zolpidem 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for sleep : Please give via PEG.
Gabapentin 300 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for dysesthetic leg pain: Please give via PEG.
Lorazepam 0.5-1 mg IV Q8H:PRN anxiety 11.
Heparin Flush (10 units/ml) 2 mL IV PRN line flush PICC, heparin dependent: Flush with 10mL Normal Saline followed by Heparin as above daily and PRN per lumen.
MetRONIDAZOLE (FLagyl) 500 mg IV Q8H 13.
Insulin Regular Human 100 unit/mL Solution Sig: AS DIR units Injection four times a day: sliding scale.
You underwent neurosurgery for a procedure called a laminectomy.
You are currently begin treated with Flagyl for a 14 day course for a previously postive C. diff toxin.
Repeat C. diff toxin in negative.
The last day of treatment with Flagyl will be on [**2173-11-12**].
